Clinical Trials Browser

Phase 4 × remimazolam × 1 year × Clear all

NCT04532606 2025-07-30

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Phase 4 Recruiting

Emergence Delirium, Urinary Bladder Neoplasms, Delirium